VariZIG (varicella zoster immune globulin) / Kamada  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VariZIG (varicella zoster immune globulin) / Kamada
NCT00338442: Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

Approved for marketing
N/A
US
VariZIG™
Cangene Corporation
Varicella
12/09
12/09

Download Options